methylene blue and semaglutide New Programs Methylene Blue Protocol

The STEP (Semaglutide Treatment Effect in People with Obesity) trials represent the most comprehensive safety data available for semaglutide at the 2.4 mg weight loss dose

Thank you for the opportunity to answer this very important question

Results of this study suggest a modest increase in the risk of NAION among individuals with type 2 diabetes associated with semaglutide use, smaller than that previously reported, and warranting further investigation into the clinical implications of this association, the study concluded

Patients should be specific about dose strengths

Sadly, the vast majority of patients who lose weight while taking Ozempic or Wegovy report rebound weight gain that equals or exceeds the amount of weight they lost

They can help you address emotional eating or other psychological factors that might affect your weight